TY - JOUR
T1 - Status quo of pain-related patient-reported outcomes and perioperative pain management in 10,415 patients from 10 countries
T2 - Analysis of registry data
AU - Zaslansky, Ruth
AU - Baumbach, Philipp
AU - Komann, Marcus
AU - Meissner, Winfried
AU - Weinmann, Claudia
AU - Mi, Weidong
AU - Liu, Yanhong
AU - Ma, Yulong
AU - Feng, Yi
AU - Jiang, Bailin
AU - Mu, Dong Liang
AU - Kang, Rongtian
AU - Wang, Hongwei
AU - Luo, Tao
AU - Chen, Xiangdong
AU - Yan, Dong
AU - Liao, Qin
AU - Yao, Juan
AU - Li, Li
AU - Yang, Guiying
AU - van Boekel, Rianne
AU - Steegers, Monique
AU - Rijsdijk, Mienke
AU - van Dijk, Jacqueline
AU - Rekker, Sjaak
AU - Olthof, Kees
AU - Giezeman, Maurice J.M.M.
AU - Koning, Nick J.
AU - Rinia, Myra
AU - Cheuk-Alam, Juanita M.
AU - Timmerman, Leon
AU - Garduño-López, Ana Lilia
AU - Nava, Victor Manuel Acosta
AU - Garcés, Lisette Castro
AU - Rascón-Martínez, Dulce María
AU - Cuellar-Guzmán, Luis Felipe
AU - Flores-Villanueva, Maria Esther
AU - Villegas-Sotelo, Elizabeth
AU - Carrillo-Torres, Orlando
AU - Vilchis-Sámano, Hugo
AU - Calderón-Vidal, Mariana
AU - Islas-Lagunas, Gabriela
AU - Stamenkovic, Dusica
AU - Bojic, Suzana
AU - Gacic, Jasna
AU - Jukic, Aleksandra
AU - Raspopovic, Emilija Dubljanin
AU - Palibrk, Ivan
AU - Polanco-García, Mauricio
AU - Huygen, Frank J.M.
N1 - Funding Information:
[i] European Community’s Seventh Framework Programme FP7/2007–2013 under Grant Agreement No. 223590; [ii] Unrestricted educational grants for quality improvement studies from Pfizer Global Medical Grants (Mexico and China); [iii] European Pain Federation (EFIC) and Grünenthal GmbH within their CHANGE PAIN® acute initiative (Belgium, Italy, Ireland, France, The Netherlands, Spain, Switzerland); [iv] EFIC (Serbia).
Funding Information:
PAIN OUT was developed with funding from the European Community's Seventh Framework Programme FP7/2007–2013 under Grant Agreement No. 223590. The sponsor had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. Pfizer Global Medical Grants provided two unrestricted educational grants to carry out pre‐ post‐ Quality Improvement (QI) studies in 10 hospitals in México (grant received February 2016) and in 10 hospitals in China (grant received December, 2017). Funding covered: [i] the cost of the annual subscription to PAIN OUT for hospitals over a 2‐year period, [ii] travel so that the Principal Investigator and one research surveyor from each participating hospital could join two half day face‐to‐face meetings to review the findings and [iii] partial remuneration to hospitals for datasets collected. The manuscript here describes the first phase of these projects. The trial protocol, analysis plan, analysis itself or any drafts of the manuscript were not requested or sent prior to submission for publication to Pfizer Global Medical Grants. Grünenthal GmbH, within the CHANGE PAIN® acute initiative, provided EFIC (European Pain Federation) funding to cover costs of QI projects in seven European countries, which included the: [i] annual subscription to PAIN OUT for hospitals over a 2‐year period; [ii] two half day face‐to‐face meetings so that the Principal Investigator and one research surveyor from each hospital could review the findings and [iii] partial remuneration to hospitals for datasets collected. PAIN OUT received the funding in two instalments, August 2017 and June, 2018. The manuscript here describes the first phase of these projects. The analysis or any drafts of this manuscript were not requested or sent prior to submission for publication to Grünenthal GmbH. EFIC provided funding from its own resources to cover costs of the project in Serbia. Funding included: [i] annual subscription to PAIN OUT for hospitals over a 2‐year period; [ii] two half day face‐to‐face meetings so that the Principal Investigator and one research surveyor from each hospital could review the findings and [iii] partial remuneration to hospitals for datasets collected. The funds were transferred to the Serbian Pain Association, who then contacted each of the participating hospitals.
Publisher Copyright:
© 2022 The Authors. European Journal of Pain published by John Wiley & Sons Ltd on behalf of European Pain Federation - EFIC ®.
PY - 2022/11
Y1 - 2022/11
N2 - Background: Postoperative pain is common at the global level, despite considerable attempts for improvement, reflecting the complexity of offering effective pain relief. In this study, clinicians from Mexico, China, and eight European countries evaluated perioperative pain practices and patient-reported outcomes (PROs) in their hospitals as a basis for carrying out quality improvement (QI) projects in each country. Methods: PAIN OUT, an international perioperative pain registry, provided standardized methodology for assessing management and multi-dimensional PROs on the first postoperative day, in patients undergoing orthopaedic, general surgery, obstetric & gynaecology or urological procedures. Results: Between 2017 and 2019, data obtained from 10,415 adult patients in 105 wards, qualified for analysis. At the ward level: 50% (median) of patients reported worst pain intensities ≥7/10 NRS, 25% spent ≥50% of the time in severe pain and 20–34% reported severe ratings for pain-related functional and emotional interference. Demographic variables, country and surgical discipline explained a small proportion of the variation in the PROs, leaving about 88% unexplained. Most treatment processes varied considerably between wards. Ward effects accounted for about 7% and 32% of variation in PROs and treatment processes, respectively. Conclusions: This comprehensive evaluation demonstrates that many patients in this international cohort reported poor pain-related PROs on the first postoperative day. PROs and treatments varied greatly. Most of the variance of the PROs could not be explained. The findings served as a basis for devising and implementing QI programmes in participating hospitals. Significance: In preparation for quality improvement projects, we comprehensively evaluated pain-related patient-reported outcomes (PROs) and treatment practices of 10,415 adult patients spanning 10 countries. PROs were generally poor. Demographics, country and surgical discipline explained a small proportion of variation for the PROs, about 88% remained unexplained. Treatment practices varied considerably between wards. Ward effects accounted for about 7% and 32% of variation in PROs and treatment processes, respectively. Future studies will aim to identify treatments which are associated with improved outcomes.
AB - Background: Postoperative pain is common at the global level, despite considerable attempts for improvement, reflecting the complexity of offering effective pain relief. In this study, clinicians from Mexico, China, and eight European countries evaluated perioperative pain practices and patient-reported outcomes (PROs) in their hospitals as a basis for carrying out quality improvement (QI) projects in each country. Methods: PAIN OUT, an international perioperative pain registry, provided standardized methodology for assessing management and multi-dimensional PROs on the first postoperative day, in patients undergoing orthopaedic, general surgery, obstetric & gynaecology or urological procedures. Results: Between 2017 and 2019, data obtained from 10,415 adult patients in 105 wards, qualified for analysis. At the ward level: 50% (median) of patients reported worst pain intensities ≥7/10 NRS, 25% spent ≥50% of the time in severe pain and 20–34% reported severe ratings for pain-related functional and emotional interference. Demographic variables, country and surgical discipline explained a small proportion of the variation in the PROs, leaving about 88% unexplained. Most treatment processes varied considerably between wards. Ward effects accounted for about 7% and 32% of variation in PROs and treatment processes, respectively. Conclusions: This comprehensive evaluation demonstrates that many patients in this international cohort reported poor pain-related PROs on the first postoperative day. PROs and treatments varied greatly. Most of the variance of the PROs could not be explained. The findings served as a basis for devising and implementing QI programmes in participating hospitals. Significance: In preparation for quality improvement projects, we comprehensively evaluated pain-related patient-reported outcomes (PROs) and treatment practices of 10,415 adult patients spanning 10 countries. PROs were generally poor. Demographics, country and surgical discipline explained a small proportion of variation for the PROs, about 88% remained unexplained. Treatment practices varied considerably between wards. Ward effects accounted for about 7% and 32% of variation in PROs and treatment processes, respectively. Future studies will aim to identify treatments which are associated with improved outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85138854582&partnerID=8YFLogxK
U2 - 10.1002/ejp.2024
DO - 10.1002/ejp.2024
M3 - Article
C2 - 35996995
AN - SCOPUS:85138854582
SN - 1090-3801
VL - 26
SP - 2120
EP - 2140
JO - European Journal of Pain (United Kingdom)
JF - European Journal of Pain (United Kingdom)
IS - 10
ER -